Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancer ; volume:12 ; number:1 ; day:8 ; month:12 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (8.12.2022), 1-13, 12.2022
- Urheber
-
Rashid, Narmeen S.
Boyd, David C.
Olex, Amy L.
Grible, Jacqueline M.
Duong, Alex K.
Alzubi, Mohammad A.
Altman, Julia E.
Leftwich, Tess J.
Valentine, Aaron D.
Hairr, Nicole S.
Zboril, Emily K.
Smith, Timothy M.
Pfefferle, Adam D.
Dozmorov, Mikhail G.
Harrell, J. Chuck
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-25541-3
- URN
-
urn:nbn:de:101:1-2023021809104130460146
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rashid, Narmeen S.
- Boyd, David C.
- Olex, Amy L.
- Grible, Jacqueline M.
- Duong, Alex K.
- Alzubi, Mohammad A.
- Altman, Julia E.
- Leftwich, Tess J.
- Valentine, Aaron D.
- Hairr, Nicole S.
- Zboril, Emily K.
- Smith, Timothy M.
- Pfefferle, Adam D.
- Dozmorov, Mikhail G.
- Harrell, J. Chuck
- SpringerLink (Online service)
Ähnliche Objekte (12)
ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Weight loss reduces basal-like breast cancer through kinome reprogramming
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors
ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Weight loss reduces basal-like breast cancer through kinome reprogramming
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors
ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Weight loss reduces basal-like breast cancer through kinome reprogramming
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer